Is Nuvation Bio Inc. (NUVB) a Buy, Sell, or Hold?
NYSE : NUVB
Nuvation Bio Inc. — Institutional Ownership
$6.16 USD
-$0.17 (-2.69%)
- Volume
- 4.71M
- Average Volume
- 6.52M
- Market Capitalization
- $2.14B
- P/E Ratio
- -14.51
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $9.75
- Year Low
- $2.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $7.44
Institutional Ownership Summary
Institutional Ownership %
0.87%
Investors Holding
47
change: -190 | last: 237
Increased Positions
22
change: -116 | last: 138
Reduced Positions
12
change: -46 | last: 58
New Positions
9
change: -37 | last: 46
Sold Positions
194
change: 157 | last: 37
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -52.0107 | last: 0.5201
Total Invested
17.12M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2025-07-17 | BlackRock, Inc. | 21.71M | 6.40% |
| 2025-05-12 | FMR LLC | 50.6M | 15.00% |
| 2025-04-28 | BlackRock, Inc. | 16.44M | 4.90% |
| 2025-02-12 | FMR LLC | 45.29M | 13.50% |
| 2024-09-10 | Decheng Capital Management III (Cayman), LLC | 1.31M | 0.40% |
| 2024-09-10 | Decheng Capital Global Healthcare GP, LLC | 7.79M | 2.30% |
| 2024-09-10 | Xiangmin Cui | 26.6M | 8.00% |
| 2024-09-10 | Decheng Capital Global Healthcare Fund (Master), LP | 7.79M | 2.30% |
| 2024-09-10 | Decheng Anbio Limited | 17.5M | 5.20% |
| 2024-09-10 | Decheng Capital China Life Sciences USD Fund III, L.P. | 1.31M | 0.40% |
| 2024-01-29 | (1) BlackRock, Inc. | 12.88M | 5.90% |
| 2023-02-13 | (1) BlackRock, Inc. | 11M | 5.00% |
| 2022-06-23 | David Kroin | 11.47M | 5.26% |
| 2022-06-23 | Deep Track Biotechnology Master Fund, Ltd. | 11.47M | 5.26% |
| 2022-06-23 | Deep Track Capital, LP | 11.47M | 5.26% |
| 2022-02-11 | Mr. Allan Weine | 215.43K | 0.10% |
| 2022-02-11 | CC ARB West, LLC | 180.58K | 0.08% |
| 2022-02-11 | Castle Creek Arbitrage, LLC | 215.43K | 0.10% |
| 2022-02-11 | CC Arbitrage, Ltd | 34851.0 | 0.02% |
| 2021-05-10 | FMR LLC | 32.28M | 14.90% |
| 2021-05-10 | Abigail P. Johnson | 32.28M | 14.90% |
| 2021-02-19 | David Hung, M.D. | 59.65M | 27.40% |
| 2021-02-19 | Claudio Nessi | 28.21M | 13.00% |
| 2021-02-19 | Michelle Doig | 28.21M | 13.00% |
| 2021-02-19 | Otello Stampacchia | 28.21M | 13.00% |
| 2021-02-19 | Omega Fund V, L.P. | 28.21M | 13.00% |
| 2021-02-19 | Omega Fund V GP, L.P. | 28.21M | 13.00% |
| 2021-02-19 | Omega Fund V GP Manager, Ltd. | 28.21M | 13.00% |
| 2021-02-19 | Anne-Marie Paster | 28.21M | 13.00% |
| 2021-02-16 | Highbridge Tactical Credit Master Fund, L.P. | 357.76K | 2.41% |
| 2021-02-16 | Castle Creek Arbitrage, LLC | 1.23M | 8.26% |
| 2021-02-16 | CC Arbitrage, Ltd | 194.04K | 1.31% |
| 2021-02-16 | Mr. Allan Weine | 1.23M | 8.26% |
| 2021-02-16 | CC ARB West, LLC | 1.03M | 6.96% |
| 2021-02-16 | Highbridge Capital Management, LLC | 357.76K | 2.41% |
| 2021-02-11 | Phillip Gross | 500K | 3.36% |
| 2021-02-11 | Adage Capital Partners, L.P. | 500K | 3.36% |
| 2021-02-11 | Adage Capital Advisors, L.L.C. | 500K | 3.36% |
| 2021-02-11 | Adage Capital Partners GP, L.L.C. | 500K | 3.36% |
| 2021-02-11 | Robert Atchinson | 500K | 3.36% |
| 2021-02-08 | EcoR1 Capital, LLC | 3.16M | 17.20% |
| 2021-02-08 | EcoR1 Panacea Holdings, LLC | 3.16M | 17.20% |
| 2021-02-08 | Biotech Opportunity GP, LLC | 3.16M | 17.20% |
| 2021-02-08 | Oleg Nodelman | 3.16M | 17.20% |
| 2021-02-08 | EcoR1 Venture Opportunity Fund, L.P. | 3.16M | 17.20% |
| 2021-02-08 | EcoR1 Capital Fund Qualified, L.P. | 3.16M | 17.20% |
| 2021-02-08 | EcoR1 Capital Fund, L.P. | 3.16M | 17.20% |
| 2020-12-04 | Highbridge Tactical Credit Master Fund, L.P. | 1M | 6.76% |
| 2020-12-04 | Highbridge Capital Management, LLC | 1M | 6.76% |
| 2020-09-17 | Adage Capital Advisors, L.L.C. | 800K | 5.38% |
| 2020-09-17 | Adage Capital Partners GP, L.L.C. | 800K | 5.38% |
| 2020-09-17 | Adage Capital Partners, L.P. | 800K | 5.38% |
| 2020-09-17 | Robert Atchinson | 800K | 5.38% |
| 2020-09-17 | Phillip Gross | 800K | 5.38% |
NUVB Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $8.96 | 341.54M | $3.06B | $164.09M | $10.15M | $2.91B |
| 2024-12-31 | $2.66 | 268.77M | $714.93M | $35.72M | $8.92M | $688.13M |
| 2023-12-31 | $1.51 | 218.88M | $330.51M | $42.65M | $4.01M | $291.87M |
| 2022-12-31 | $1.92 | 216.72M | $416.1M | $101.1M | $4.26M | $319.27M |
| 2021-12-31 | $8.50 | 197.89M | $1.68B | $132.42M | $3.06M | $1.55B |
| 2020-12-31 | $11.70 | 217.65M | $2.55B | $29.76M | -$ | $2.52B |
| 2019-12-31 | $10.00 | 206.67M | $2.07B | $3.47M | -$ | $2.06B |
| 2018-12-31 | $10.00 | 183.74M | $1.84B | $138K | $600K | $1.84B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4.29 | 347.33M | $1.49B | $125.39M | $9.83M | $1.37B |
| 2025-12-31 | $8.96 | 344.34M | $3.09B | $164.09M | $10.15M | $2.93B |
| 2025-09-30 | $3.70 | 342.39M | $1.27B | $98.9M | $57.55M | $1.23B |
| 2025-06-30 | $1.95 | 340.75M | $664.45M | $247.97M | $57.76M | $474.25M |
| 2025-03-31 | $1.76 | 338.61M | $595.96M | $47.98M | $11.41M | $559.39M |
| 2024-12-31 | $2.66 | 336.93M | $896.24M | $35.72M | $8.92M | $869.44M |
| 2024-09-30 | $2.29 | 273.56M | $626.46M | $30.04M | $11.19M | $607.62M |
| 2024-06-30 | $3.16 | 244.74M | $773.37M | $34.28M | $14.68M | $753.77M |
| 2024-03-31 | $3.69 | 219.05M | $808.29M | $34.51M | $3.53M | $777.31M |
| 2023-12-31 | $1.51 | 218.91M | $330.55M | $42.65M | $4.01M | $291.91M |
| 2023-09-30 | $1.34 | 218.94M | $293.37M | $24.4M | $4.46M | $273.44M |
| 2023-06-30 | $1.80 | 218.85M | $393.93M | $50.06M | $3.68M | $347.54M |